🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Immune checkpoint inhibitors are used to treat many types of cancer, but talking with patients about immunotherapy can be confusing. Ronac Mamtani Erin Bange MD MSCE and I developed a JAMA Oncology Patient Page to help clinicians and patients with this conversation. jamanetwork.com/journals/jamao…

1⃣ in 5⃣ patients receiving immunotherapy may experience a related adverse event. PC3I's Tim Brown, MD MSCE Erin Bange MD MSCE Ronac Mamtani developed a JAMA Oncology #PatientPage to support clinician-patient conversations about these events. Check it out and share: bit.ly/3bnBq7r

Super excited about this trial led by Erin Bange MD MSCE , refined by AACR ASCO Vail Methods in Clinical Cancer Workshop, and funded by Conquer Cancer, the ASCO Foundation.

Excited to be part of this #dreamteam! Tim Brown, MD MSCE Ronac Mamtani Carmen Guerra Penn Cancer Innovation

Our JAMA Oncology #PatientPage on immunotherapy-related adverse events. Free to print/share with patients or anyone interested. Erin Bange MD MSCE Ronac Mamtani

Check out our phase 1 CAR-M study in progress at the Developmental Therapeutics session Sunday AM. Excited to meet you at 327b and discuss other new cell therapy work at #ASCO2022 Kim Reiss Binder (Kim Reiss)

Amazing work by Conquer Cancer, the ASCO Foundation YIA recipient Erin Bange MD MSCE on using symptom monitoring to improve amount of time patients spend on cancer care #ASCO22

We’re currently testing if patients without symptoms of immunotherapy-related toxicity identified by SMS can be triaged to fast-track IO infusions without an associated clinic visit. See more ⬇️⬇️ w all-star team Erin Bange MD MSCE Ronac Mamtani kerrycoughlin.bsky.social Penn Cancer Innovation

I am incredibly excited to join the MSK team and help improve patient care with some awesome health services researchers!

"Early in medical school, we learned that only 20% of healthcare occurs within a doctor’s office. The other 80% originates outside the medical setting, where social determinants of health — one’s home, work, etc — are far more influential" Carmen Guerra everydayhealth.com/lung-cancer/wo…

We’re also appreciative of the patients who were willing to participate and the manuscript reviewers JAMA Network Open who strengthened the paper and it’s conclusions

"You don't live longer, it just seems longer" #TimeToxicity steals meaningful moments at home from our patients with serious illness. ➡️fal.cn/3rzeF

Dr Christopher Jenson UNC Lineberger presenting on #TimeToxicity #HomeTime in older patients with #AML. High intensity treatment improved survival BUT meant most of that time was SPENT IN THE HOSPITAL and/or AWAY from HOME. ASCO #ASCOQLTY22 cc Dr Arjun Gupta Erin Bange MD MSCE

#PC3IatASCO Do clinical pathways impede provider workflow: A provider efficiency analysis of time spent using an EHR-embedded clinical decision support tool. Abstract 381 Poster E20 meetings.asco.org/abstracts-pres… @gregcalip Erin Bange MD MSCE Aditi Singh #ASCOQLTY22 pc3i.upenn.edu/pc3i-presents-…

#PC3IatASCO: Collab w/ Flatiron Health, led by PC3I's Christopher D'avella & Lawrence Shulman w/ team David W Dougherty Erin Bange MD MSCE Aditi Singh present on value of #EMR based clinical pathways tool to improve #clinician workflow. #ASCO #ASCO23 ASCO meetings.asco.org/abstracts-pres…

#PC3IatASCO: PC3I's Ronac Mamtani & team Erin Bange MD MSCE kerrycoughlin.bsky.social Tim Brown, MD MSCE explore #timetoxicity & oncologists' perceptions of digital interventions in #cancercare. #ASCO #ASCO23 ASCO meetings.asco.org/abstracts-pres…

📢In many ways, #telemedicine is true patient-centered care. Fumiko Ladd Chino, MD, FASCO, Erin Bange, & I wrote this piece about how health care systems highlight desire to be pt-centered but offer telemedicine sparingly or begrudgingly. Why are we not walking the walk? rdcu.be/dfpaM

💻📲 Rapidly deployed during the pandemic, #telemedicine has now been sharply scaled back. Continued offering of a #Telehealth visit option may allow true patient-centered care. New editorial in NatureRevClinOncol: how to walk the walk for patient access. rdcu.be/dfpaM

Finally...a study on how to reduce time toxicity, rather than another study that quantifies it. Led by Erin Bange MD MSCE supported by Conquer Cancer, the ASCO Foundation Penn Cancer Innovation Tim Brown, MD MSCE kerrycoughlin.bsky.social Carmen Guerra Lynn Schuchter Penn Medicine - Abramson Cancer Center

A study led by Erin Bange MD MSCE & Penn Medicine assessed text messaging to help people with cancer spend less time in the clinic. Patients who had normal bloodwork and reported no symptoms could skip an extra visit, saving about an hour per appointment. bit.ly/3EWgshN